D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction

Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers

(2018) Patricia Di Ciano et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Gemfibrozil has antidepressant effects in mice: Involvement of the hippocampal brain-derived neurotrophic factor system

(2018) Yu-Fei Ni et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms

(2018) Claudia Cristiano et al.   BRAIN BEHAVIOR AND IMMUNITY

Occupancy of dopamine D2 and D3 receptors by a novel D3 partial agonist BP1.4979: a [11C]-(+)-PHNO PET study in humans

(2018) Patricia Di Ciano et al.   NEUROPSYCHOPHARMACOLOGY

WY-14643, a selective agonist of peroxisome proliferator-activated receptor-α, ameliorates lipopolysaccharide-induced depressive-like behaviors by preventing neuroinflammation and oxido-nitrosative stress in mice

(2017) Rongrong Yang et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Corticotropin-releasing hormone and dopamine release in healthy individuals

(2017) Doris Payer et al.   PSYCHONEUROENDOCRINOLOGY

Time-dependent effects of repeated THC treatment on dopamine D2/3 receptor-mediated signalling in midbrain and striatum

(2016) Benjamin B. Tournier et al.   BEHAVIOURAL BRAIN RESEARCH

Antidepressant-like effects of fenofibrate in mice via the hippocampal brain-derived neurotrophic factor signalling pathway

(2016) Bo Jiang et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Fatty Acid Amide Hydrolase C385A Variant Affects Brain Binding of the Positron Emission Tomography Tracer [11C]CURB

(2015) Isabelle Boileau et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Endocannabinoid signalling in reward and addiction

(2015) Loren H. Parsons et al.   NATURE REVIEWS NEUROSCIENCE

D3dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia

(2015) Doris E. Payer et al.   NEUROLOGY

Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans

(2015) Bernard Le Foll et al.   NEUROPSYCHOPHARMACOLOGY

FAAH genetic variation enhances fronto-amygdala function in mouse and human

(2015) Iva Dincheva et al.   Nature Communications

Normal aging in rats and pathological aging in human Alzheimer’s disease decrease FAAH activity: Modulation by cannabinoid agonists

(2014) A.C. Pascual et al.   EXPERIMENTAL GERONTOLOGY

Risky alcohol consumption in young people is associated with the fatty acid amide hydrolase gene polymorphism C385A and affective rating of drug pictures

(2014) Kora-Mareen Bühler et al.   MOLECULAR GENETICS AND GENOMICS

FAAH selectively influences placebo effects

(2013) M Peciña et al.   MOLECULAR PSYCHIATRY

Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with [11C]-(+)-PHNO

(2013) Doris E Payer et al.   NEUROPSYCHOPHARMACOLOGY

What is the role of the D3 receptor in addiction? A mini review of PET studies with [11C]-(+)-PHNO

(2013) Doris Payer et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking

(2013) E. B. Oleson et al.   Cold Spring Harbor Perspectives in Medicine

Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area

(2012) Amelie Simonnet et al.   ADDICTION BIOLOGY

Higher Binding of the Dopamine D3 Receptor-Preferring Ligand [11C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study

(2012) I. Boileau et al.   JOURNAL OF NEUROSCIENCE

Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems

(2012) Nathalie Ginovart et al.   NEUROPSYCHOPHARMACOLOGY

Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats

(2012) K. Yaragudri Vinod et al.   PLoS One

Administration of URB597, Oleoylethanolamide or Palmitoylethanolamide Increases Waking and Dopamine in Rats

(2011) Eric Murillo-Rodríguez et al.   PLoS One

Intense exercise increases circulating endocannabinoid and BDNF levels in humans—Possible implications for reward and depression

(2011) E. Heyman et al.   PSYCHONEUROENDOCRINOLOGY

Blockade of Nicotine Reward and Reinstatement by Activation of Alpha-Type Peroxisome Proliferator-Activated Receptors

(2010) Paola Mascia et al.   BIOLOGICAL PSYCHIATRY

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy

(2010) Andri C. Tziortzi et al.   NEUROIMAGE

Biomarkers of Endocannabinoid System Activation in Severe Obesity

(2010) Jack C. Sipe et al.   PLoS One

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease

(2009) I. Boileau et al.   BRAIN

Divergent Effects of Genetic Variation in Endocannabinoid Signaling on Human Threat- and Reward-Related Brain Function

(2008) Ahmad R. Hariri et al.   BIOLOGICAL PSYCHIATRY

The endocannabinoid system in brain reward processes

(2008) M Solinas et al.   BRITISH JOURNAL OF PHARMACOLOGY

The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women

(2008) Palmiero Monteleone et al.   PSYCHONEUROENDOCRINOLOGY

Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis

(2008) Joseph P. Schacht et al.   PSYCHOPHARMACOLOGY